***********************************
Brakke 咨询公司的
Animal Health News & Notes for October 14, 2016
版权所有 © Brakke 咨询公司
编辑：Lynn Fondon DVM MBA
************************************
新闻报道：
Brakke 咨询新闻
2017 Pet Pharmaceutical Market Shift Study – early order discount extended
场外交易渠道
盈利新闻
维克
其他新闻
Bentley 的宠物用品
Boehringer Ingelheim (divestiture)
Boehringer Ingelheim (Ultra Duramune Lyme)
塞瓦
钻石宠物食品
EI 医学影像
Gimborn Holding
免疫细胞
默克
梅里亚尔
Moochie & Co
T细胞治疗公司
***********************************
布拉克咨询有限公司
2016-2017年宠物药品市场变化研究
EARLY-ORDER DISCOUNT EXTENDED ONE WEEK – DEADLINE OCTOBER 21
Brakke Consulting 和 Trone Brand Energy 欣然宣布即将开展宠物药品市场转型研究。首项研究于 2015 年完成，研究发现宠物主人希望能够自由地在兽医院外购买处方药。由于购买行为的转变，约有 25% 的诊所收入已出现下降，大多数药剂师认为，鉴于市场需求，他们应该配发更多宠物药品。
2017年的后续研究将探讨兽医需要采取哪些措施来维持客户的购买忠诚度。此外，研究还将评估兽医对制造商和分销商直接向人类药房或互联网销售的态度和反应，以及制造商和分销商可以采取哪些措施来帮助兽医维持客户忠诚度。
该研究将于 2017 年初完成。如需了解更多信息，请联系 David Goodnight（电话：830-285-1259）或 dgoodnight@brakkeconsulting.com.
***********************************
公司业绩发布
• Virbac SA reported results for the third quarter of 2016. Consolidated sales in the third quarter amounted to EUR 216 million ($242 million), an increase of 1% compared to the same period of 2015. (+2% at constant exchange rates). (company website)
**********************************
公司新闻稿
• Boehringer Ingelheim, Merial and Ceva Santé Animale announced that Boehringer Ingelheim and Ceva have entered into a binding put option agreement according to which Ceva will purchase certain assets of Merial’s portfolio in the context of Boehringer Ingelheim’s business swap with Sanofi. Ceva will acquire certain animal health vaccines and pharmaceuticals from the Merial portfolio for swine, bovine and companion animals as well as related intellectual property, manufacturing processes and R&D activities. The package contains the following brands: Circovac (excluding US), Progressis, Mucosiffa, Parvovax, Parvoruvax, Equioxx (excluding US), Genixine, Ketofen 1% injection and tablets (excluding Canada) and Ketofen 10% injection (excluding Canada). (company press release)
• Merck Animal Health announced that the USDA has approved a license for Nobivac Canine Flu Bivalent vaccine. According to the company it is the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8. (company press release)
• Boehringer Ingelheim Vetmedica Inc. (BIVI) announced the launch of Ultra Duramune Lyme, a new low-volume 0.5 mL vaccine for subcutaneous vaccination of healthy dogs 9 weeks of age or older as an aid in the prevention of disease caused by Borrelia burgdorferi. (company website)
• ImmuCell Corporation announced that it has broken ground on construction of its new $20 million pharmaceutical facility to produce Nisin, the active ingredient in Mast Out. The two-story facility in Portland, Maine, will provide over 16,800 square feet of fermentation, processing, laboratory and warehouse space. (company press release)
• T-Cyte Therapeutics, Inc., announced the US launch of Lymphocyte T-Cell Immunomodulator (LTCI) as the first USDA-approved treatment option for canine osteoarthritis. LTCI is administered by veterinarians via a subcutaneous injection. (Marketwired.com)
• Diamond Pet Foods announced it has entered the veterinary channel with the introduction of Diamond Care Rx Renal Formula for adult dogs. The diet is available exclusively at veterinary clinics. Diamond also launched four other Diamond Care pet food formulas that are sold at pet stores nationwide. (Veterinary Practice News)
• E.I. Medical Imaging announced the release of EVOStream, a wireless technology that allows users to view live ultrasound images on mobile devices. (Digitaljournal.com)
• Penta Investments announced it has sold Gimborn Holding GmbH to Hillhouse Capital Management, a long-term equities investor with significant investments in Asia. According to the company’s CEO, under Hillhouse management Gimborn can accelerate its planned expansion into Asia. Financial terms were not disclosed. (PETS International)
• Natural pet food retailer Bentley’s Pet Stuff has merged with Moochie & Co., an 11-store mall-based pet supply store chain in Ohio, Indiana and Kentucky. Financial terms were not disclosed. (Pet Business)
***********************************
动物健康新闻
• US – BOVINE VACCINE Researchers at Kansas State University have developed a new vaccine as an antibiotic-free method to prevent the transmission of Fusobacterium necrophorum in sheep and cattle to meat consumers. The vaccine uses a two-pronged approach to immunize livestock against leukotoxins produced by F. necrophorum. (AVMA Smartbrief – Healio)
• US – CANINE CANCER TEST North Carolina State University’s College of Veterinary Medicine has filed a patent application with the U.S. Patent and Trademark Office for a DNA test for canine transitional cell carcinoma. (Wraltechwire.com)
• US – THERAPY DOGS The Human Animal Bond Research Initiative (HABRI) announced it has awarded a $79,000 grant to the University of Tennessee College of Veterinary Medicine for a new study, “The Effect of Animal-Assisted Intervention on Preoperative Anxiety and Dose of Sedation in Children.” The goal of the three-year, cross-over-designed study is to determine if interaction with a therapy dog 20 minutes prior to surgery has a significant effect on reducing a child’s anxiety levels and, in turn, lowering the dose of medication necessary for sedation. (PRWeb.com)
************************************
布拉克咨询有限公司
了解场外交易市场
无论您的业务是考虑通过 OTC 渠道寻找新的商机，还是多年来一直在 OTC 渠道分销，Brakke Consulting 的团队都可以为寻求更多了解 OTC 分销渠道细节的企业提供重要且优质的帮助。如果您正在寻找有关 OTC 渠道、那里的趋势以及存在的机会的有意义的见解，请联系我们的达拉斯办事处或 Joel Adamson jadamson@brakkeconsulting.com.
www.BrakkeConsulting.com
************************************
BRAKKE 咨询观点
It appears with a second divestiture of some Merial assets that the Boehringer and Merial merger is approaching completion as planned. There were other announcements this week related to animal health or pet product assets changing hands. Currently, several companies are aggressively expanding investment in the vaccine area. Prevention versus therapy is increasing in importance in health programs because of both economics and concerns over antibiotic usage. Early stage companies and universities with new platform vaccine technologies or vaccines will find a high level of interest at manufacturer, distributor and veterinary level. There also appears to be a fair amount of repositioning by a number of companies to adjust to competitive consolidations.
As for myself I have just arrived in South Dakota to assist in the annual ring neck pheasant harvest that begins this weekend. It is also a good time to check out the crops and attitudes of producers in my home state. Have a great weekend!
罗恩·布拉克
**********************************
本电子通讯归 Brakke Consulting, Inc. 独有。
对本文内容的任何使用均须经过 Brakke Consulting, Inc. 的批准并适当注明来源。
有关 Brakke Consulting 服务和联合研究的更多信息，请访问我们的网站 www.brakkeconsulting.com.
Brakke 咨询公司
12005 福特路，530 室
美国德克萨斯州达拉斯 75234
Chinese 
English 
Portuguese 
Japanese